Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Echinococcus granulosus | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | peptidyl-prolyl cis-trans isomerase | 0.0184 | 0.1242 | 0.5 |
Loa Loa (eye worm) | FKBP-type peptidyl-prolyl cis-trans isomerase-12 | 0.1334 | 0.9886 | 1 |
Echinococcus multilocularis | FK506 binding protein 8, 38 kDa | 0.0199 | 0.1357 | 0.0131 |
Mycobacterium leprae | PROBABLE TRIGGER FACTOR (TF) PROTEIN TIG | 0.0184 | 0.1242 | 0.5 |
Schistosoma mansoni | immunophilin | 0.1349 | 1 | 1 |
Trichomonas vaginalis | peptidylprolyl isomerase, putative | 0.1334 | 0.9886 | 1 |
Onchocerca volvulus | 0.0187 | 0.1265 | 1 | |
Entamoeba histolytica | peptidyl-prolyl cis-trans isomerase, FKBP-type , putative | 0.1349 | 1 | 1 |
Toxoplasma gondii | peptidyl-prolyl isomerase FKBP12, putative | 0.0184 | 0.1242 | 0.5 |
Trichomonas vaginalis | immunophilin, putative | 0.1334 | 0.9886 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 0.2929 | 0.1926 |
Treponema pallidum | peptidyl-prolyl cis-trans isomerase, FKBP-type, 22 kDa (fklB) | 0.1334 | 0.9886 | 1 |
Echinococcus multilocularis | fk506 binding protein | 0.1334 | 0.9886 | 0.9869 |
Wolbachia endosymbiont of Brugia malayi | FKBP-type peptidylprolyl isomerase | 0.0184 | 0.1242 | 0.5 |
Loa Loa (eye worm) | FKBP-type peptidyl-prolyl cis-trans isomerase-13 | 0.0184 | 0.1242 | 0.0972 |
Leishmania major | FKBP-type peptidyl-prolyl cis-trans isomerase, putative | 0.0184 | 0.1242 | 0.1257 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase, putative | 0.1334 | 0.9886 | 1 |
Loa Loa (eye worm) | FKBP-type peptidyl-prolyl cis-trans isomerase-30 | 0.0184 | 0.1242 | 0.0972 |
Schistosoma mansoni | fk506 binding protein | 0.0184 | 0.1242 | 0.096 |
Trypanosoma cruzi | FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative | 0.1334 | 0.9886 | 1 |
Leishmania major | peptidylprolyl isomerase-like protein | 0.1334 | 0.9886 | 1 |
Trypanosoma brucei | FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative | 0.1334 | 0.9886 | 1 |
Echinococcus granulosus | tumor protein p63 | 0.0408 | 0.2929 | 0.1926 |
Giardia lamblia | 70 kDa peptidylprolyl isomerase, putative | 0.1334 | 0.9886 | 1 |
Schistosoma mansoni | immunophilin | 0.1349 | 1 | 1 |
Echinococcus multilocularis | peptidyl prolyl cis trans isomerase FKBP4 | 0.1165 | 0.8621 | 0.8425 |
Trichomonas vaginalis | fk506-binding protein, putative | 0.1334 | 0.9886 | 1 |
Leishmania major | peptidyl-prolyl cis-trans isomerase, putative | 0.0184 | 0.1242 | 0.1257 |
Schistosoma mansoni | immunophilin | 0.1165 | 0.8621 | 0.8576 |
Wolbachia endosymbiont of Brugia malayi | FKBP-type peptidylprolyl isomerase | 0.0184 | 0.1242 | 0.5 |
Echinococcus granulosus | peptidyl prolyl cis trans isomerase FKBP4 | 0.1165 | 0.8621 | 0.8425 |
Loa Loa (eye worm) | FKBP5 protein | 0.1334 | 0.9886 | 1 |
Giardia lamblia | FKBP-type peptidyl-prolyl cis-trans isomerase | 0.1334 | 0.9886 | 1 |
Toxoplasma gondii | peptidyl-prolyl cis-trans isomerase, FKBP-type domain-containing protein | 0.0184 | 0.1242 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.1242 | 0.0972 |
Plasmodium vivax | 70 kDa peptidylprolyl isomerase, putative | 0.1334 | 0.9886 | 1 |
Mycobacterium ulcerans | FK-506 binding protein, peptidyl-prolyl cis-trans isomerase | 0.1334 | 0.9886 | 1 |
Brugia malayi | FKBP-type peptidyl-prolyl cis-trans isomerase-59, BmFKBP59 | 0.1337 | 0.9908 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0184 | 0.1242 | 0.096 |
Schistosoma mansoni | immunophilin FK506 binding protein FKBP12 | 0.1334 | 0.9886 | 0.9882 |
Echinococcus multilocularis | peptidyl prolyl cis trans isomerase FKBP4 | 0.1349 | 1 | 1 |
Onchocerca volvulus | 0.0184 | 0.1242 | 0.9822 | |
Loa Loa (eye worm) | hypothetical protein | 0.1153 | 0.8529 | 0.8583 |
Toxoplasma gondii | peptidyl-prolyl cis-trans isomerase, FKBP-type domain-containing protein | 0.0184 | 0.1242 | 0.5 |
Toxoplasma gondii | peptidyl-prolyl cis-trans isomerase, FKBP-type domain-containing protein | 0.0184 | 0.1242 | 0.5 |
Echinococcus granulosus | peptidyl prolyl cis trans isomerase FKBP1A | 0.1334 | 0.9886 | 0.9869 |
Entamoeba histolytica | peptidyl-prolyl cis-trans isomerase, FKBP-type, putative | 0.1349 | 1 | 1 |
Onchocerca volvulus | 0.006 | 0.0312 | 0.2464 | |
Trypanosoma brucei | peptidyl-prolyl cis-trans isomerase, putative | 0.1334 | 0.9886 | 1 |
Plasmodium falciparum | peptidyl-prolyl cis-trans isomerase FKBP35 | 0.1334 | 0.9886 | 1 |
Brugia malayi | FKBP-type peptidyl-prolyl cis-trans isomerase-12, BmFKBP-12 | 0.1334 | 0.9886 | 0.9974 |
Leishmania major | peptidyl-prolyl cis-trans isomerase, macrophage infectivity potentiator precursor, putative | 0.0184 | 0.1242 | 0.1257 |
Trichomonas vaginalis | peptidylprolyl isomerase, putative | 0.1334 | 0.9886 | 1 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase, putative | 0.1334 | 0.9886 | 1 |
Leishmania major | fk506-binding protein 1-like protein | 0.1334 | 0.9886 | 1 |
Trypanosoma cruzi | FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase, putative | 0.1334 | 0.9886 | 1 |
Loa Loa (eye worm) | FKBP-type peptidyl-prolyl cis-trans isomerase-33 | 0.0184 | 0.1242 | 0.0972 |
Mycobacterium tuberculosis | Probable trigger factor (TF) protein Tig | 0.0184 | 0.1242 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.8913 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 1 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 1.9953 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.